|
| |
Articles
1-100 out of 100 article(s)
| Title |
Author |
Type |
Date |
Words |
| New drug offers relief for arthritis: anti-inflammatory injections work when other meds don't. |
Seppa, Nathan |
|
Aug 1, 2009 |
339 |
| New uses for Botox. |
|
Brief article |
Jul 1, 2009 |
190 |
| Discovering and developing new medications--the long and challenging journey. |
Andrews, William T. |
|
Jun 22, 2009 |
577 |
| Vaccine tests kill 12 infants in Argentina. |
Gerson, Charlotte |
|
May 1, 2009 |
364 |
| Media may be biased against herbal remedies. |
Ninger, Laura J. |
Brief article |
May 1, 2009 |
211 |
| No more heart attacks! |
Faloon, William |
Report |
May 1, 2009 |
7938 |
| Biocom panel looks at impact of outsourcing. |
Chambers, Heather |
|
Apr 13, 2009 |
401 |
| Expanding access to investigational drugs for treatment use: a policy analysis and legislative proposal. |
Winniford, Austin |
|
Jan 1, 2009 |
18198 |
| Stepping up to the plate for MS research. |
Richert, John R. |
Report |
Dec 22, 2008 |
833 |
| Meeting the challenge of HP-API demand Growth. |
Feldker, Dave |
|
Sep 1, 2008 |
1391 |
| That's jazz! At Infinity Pharmaceuticals, individual inspiration sparks a collective performance like none other, and the Cambridge, Massachusetts-based biotechnology company isn't shy about trumpeting its jazz influences--or its bold ambition to beat cancer. |
Seapy, Sheryl |
|
Sep 1, 2008 |
1426 |
| Sea the new drugs? With the need for more APIs, researchers are plumbing the ocean depths in search of new drugs. Andrew Levy reports on the efforts of Nereus Pharmaceuticals. |
Levy, Andrew |
|
Sep 1, 2008 |
1042 |
| How to find a CRA: with the number of clinical trials continuing to rise, there is growing pressure on companies to find, appoint and retain good CRAs (Clinical Research Associates). But finding the right CRA for the job is proving increasingly difficult. Alex Gilmore, Director of recruitment consultants Oxygen Life Science Solutions, explains why CRAs have become such a rare breed. |
Gilmore, Alex |
|
Sep 1, 2008 |
780 |
| Take two and run farther in the morning: drugs improve muscular endurance in lab mice. |
Barry, Patrick |
|
Aug 30, 2008 |
379 |
| Location matters. |
Maxmen, Amy |
|
Aug 2, 2008 |
669 |
| GlaxoSmithKline invests in resveratrol research. |
Kiefer, Dale |
Brief article |
Jul 1, 2008 |
277 |
| Smarter, faster and cost-effective liquid handling: assay miniaturization using tips with capillary pockets for nanolitre dispensing. |
Williams, Kiara |
Report |
Jul 1, 2008 |
1574 |
| Canadian legal oversight of pharmacogenomics and nutrigenomics. |
Morin, Karine |
|
Jun 22, 2008 |
6944 |
| Improved effectiveness in laboratory asset management: pharmaceutical and biotech companies are under unprecedented pressure to improve efficiency across drug discovery, development and production. One approach is to engage an external multi-vendor asset management service to maintain all laboratory instruments. But what are the benefits of using an asset management service and what can be expected? |
Black, Fraser |
|
May 1, 2008 |
1401 |
| U.K. researcher raises 'red flag' on new drugs. |
|
|
Apr 8, 2008 |
315 |
| Clever marketers have long understood that the more something costs, the better people assume it must be. |
|
Brief article |
Apr 7, 2008 |
152 |
| What's in the pipeline: a look at antipsychotic agents in development. |
Glazer, William M. |
|
Dec 1, 2007 |
1224 |
| Editorial. |
Scheer, Rainer |
|
Oct 1, 2007 |
1109 |
| 45. Immuno-PCR--highly sensitive protein detection: results of the detection of native mistletoe lectin in human serum samples. |
Adler, M.; Eisenbraun, J. |
|
Oct 1, 2007 |
313 |
| ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats. |
Ninahuaman, M.F.M.L.; Souccar, C.; Lapa, A.J.; Lima-Landman, M.T.R. |
Clinical report |
May 1, 2007 |
4207 |
| Inhibition of histamine-induced bronchospasm in guinea pigs treated with Cecropia glaziovi Sneth and correlation with the in vitro activity in tracheal muscles. |
Delarcina, S., Jr.; Lima-Landman, M.T.R.; Souccar, C.; Cysneiros, R.M.; Tanae, M.M.; Lapa, A.J. |
Clinical report |
May 1, 2007 |
3090 |
| Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development. |
Wu, K.M.; Farrelly, J.G.; Upton, R.; Chen, J. |
|
Apr 1, 2007 |
3959 |
| Biotechnology. |
|
Brief article |
Mar 15, 2007 |
193 |
| Rights, roles and responsibilities of caregivers, industry and government debated. |
|
|
Mar 12, 2007 |
910 |
| Torcetrapib's failure may not doom HDL raisers: increased mortality may be related to the drug's hypertensive effects and to accelerated atherogenesis. |
Sullivan, Michele G. |
|
Mar 1, 2007 |
958 |
| Chew yourself to a new body. |
Bateman, Chris |
Brief article |
Mar 1, 2007 |
90 |
| Editorial. |
Kohler, S.; Wagner, H. |
Editorial |
Feb 1, 2007 |
385 |
| Validity of some MDS Pharma studies questioned by agency; pending NDAs could be delayed. |
Pickett, Joseph |
|
Jan 1, 2007 |
732 |
| Glass houses: cancer specialist attacks alternative therapies. |
|
|
Jan 1, 2007 |
493 |
| Technology unbound: will funded libertarianism dominate the future? |
Goldberg, Steven |
|
Jan 1, 2007 |
5944 |
| Meeting explores pricing of pharmaceutical products. |
|
|
Jun 1, 2006 |
872 |
| Cultivating the superbugs--biological friends and enemies. |
Wolff, Milo |
Editorial |
Jun 22, 2005 |
447 |
| Big pharma R&D operations make changes. |
|
|
Apr 15, 2005 |
1259 |
| United Kingdom. |
|
Brief Article |
Apr 15, 2005 |
107 |
| CMS Issues Proposed Rule on Competitive Acquisition of Part B Drugs and Biologicals. |
|
|
Mar 18, 2005 |
2096 |
| In The Beginning, There Is A License. |
Vito, Christine |
|
Jan 18, 2005 |
1046 |
| Folate. |
|
|
Dec 1, 2004 |
332 |
| Phototrop[R] (combination of acetyl-L-carnitine, highly concentrated omega 3 and coenzyme Q10). |
|
Brief Article |
Dec 1, 2004 |
177 |
| Small success. |
Webb, Marion |
Brief Article |
Nov 8, 2004 |
279 |
| InterMune extends hepatitis C drug discovery program with Array BioPharma. |
|
|
Oct 1, 2004 |
765 |
| Assessing the Role of IPRs to foster R&D: the case of vaccines and drugs for neglected diseases. |
Szogs, Astrid |
Report |
Oct 1, 2004 |
6009 |
| Failed skin cancer tests prompts maxim stock drop: shareholders file class action suit. |
Webb, Marion |
|
Sep 27, 2004 |
708 |
| Memantine shows efficacy for mild to moderate AD in phase III study. |
Zoler, Mitchel L. |
|
Sep 1, 2004 |
728 |
| Pharmaceutical. |
|
Brief Article |
Jul 15, 2004 |
121 |
| Calendar. |
|
Calendar |
May 1, 2004 |
2124 |
| Wireless monitoring in medical research: applied BioSystems: Using wireless technology to remotely mend equipment failures. |
Barkin, Ian |
|
May 1, 2004 |
631 |
| Warner-Lambert obtains United States patent. |
|
Brief Article |
Apr 1, 2004 |
69 |
| Centro Nacional de Investigaciones Cientificas obtains United States patent. |
|
Brief Article |
Apr 1, 2004 |
58 |
| Merska obtains United States patent. |
|
Brief Article |
Apr 1, 2004 |
268 |
| NIH roadmap for medical research. |
Schmidt, Charles W. |
|
Mar 1, 2004 |
1334 |
| Calendar. |
|
Calendar |
Mar 1, 2004 |
2045 |
| Business climate survey: pharma/biotech prospects. |
|
|
Nov 15, 2003 |
791 |
| The great health grab: the world's giant drug companies pursue profit above all else. Dinyar Godrej inspects an industry that's more than a little sick. |
|
|
Nov 1, 2003 |
3108 |
| Peddling paranoia: selling cures for imaginary diseases is where the drug industry really rakes in the cash, argues Alan Cassels. Real need barely enters the picture. |
Cassels, Alan |
|
Nov 1, 2003 |
1549 |
| Epidemic, what epidemic? It's been called the most neglected disease in the world. And Big Pharma is doing what it can to keep it that way. Spring Gombe explains. |
Gombe, Spring |
|
Nov 1, 2003 |
1674 |
| Who cares about cancer? Joana Ramos spotlights a crisis that barely figures in international discussions of essential drugs. |
Ramos, Joana |
|
Nov 1, 2003 |
997 |
| Bucking the trend: the NI spoke with Yves Champey, director of a new international medical charity, the drugs for neglected diseases initiative (DNDi). |
|
Interview |
Nov 1, 2003 |
776 |
| Case studies of Big Pharma's sharp practice: Testing times. |
|
|
Nov 1, 2003 |
496 |
| Direct Wireless Communications acquired The Barnhill Group in August and Fractal Genomics in September. |
|
|
Oct 31, 2003 |
24 |
| Government. |
|
Brief Article |
Sep 15, 2003 |
124 |
| Tripos and drug discovery service company Novascreen Biosciences. |
|
Brief Article |
Aug 31, 2003 |
15 |
| Pharmaceutical: President Bush announced plans intended to bring more generic versions of brand-name drugs to the market much faster. (Industry Watch). |
|
Brief Article |
Jul 15, 2003 |
133 |
| Endpoint. |
|
Brief Article |
Jul 15, 2003 |
267 |
| Under a research access agreement, the FDA's Center for Drug Evaluation and Research is using Iconix Pharmaceuticals' DrugMatrix system. (Informatics: sales/orders of note). |
|
Brief Article |
Jul 15, 2003 |
56 |
| Glaxo drug discovery and development research grants. |
|
Brief Article |
May 30, 2003 |
136 |
| Africa: problems getting antiretrovirals for trials. |
|
|
May 30, 2003 |
543 |
| Drug smugglers leave cellular tracks. (Chemistry). |
|
Brief Article |
May 17, 2003 |
264 |
| Sorting out the vagrancies of pharmaceutical R&D. |
|
Industry Overview |
May 15, 2003 |
2206 |
| Toxicity of kava pyrones, drug safety and precautions--a case study. (Review). |
Schulze, Johannes; Raasch, Walter; Siegers, Claus-Peter |
|
May 1, 2003 |
4015 |
| AIDS vaccine: the beginning of the end: October 28, 1986. (From the Advocate Archives). |
Romesburg, Don |
Brief Article |
Apr 15, 2003 |
163 |
| Advances in hormonal contraception: over time, methods have become safer, more acceptable, easier to use, and more diverse. |
Wright, Kerry L. |
|
Mar 22, 2003 |
2112 |
| Making waves. |
|
Brief Article |
Mar 1, 2003 |
868 |
| Get Your Wonder Drugs!: But do you know what it takes to produce them? |
MILLER, JOHN J. |
|
Feb 24, 2003 |
2538 |
| PALL DEBUTS SUPRACAP 60 DEPTH FILTER CAPSULE. |
|
|
Feb 1, 2003 |
394 |
| PERKINELMER UNVEILS TWO FLOW SCINTILLATION DETECTORS. |
|
|
Feb 1, 2003 |
530 |
| Long-term study suggests concerta is well tolerated. (Children with ADHD). |
Brunk, Doug |
Brief Article |
Feb 1, 2003 |
408 |
| New drug research, the extraterritorial application of FDA regulations, and the need for international cooperation. |
DuBois, William |
|
Jan 1, 2003 |
20539 |
| Newly developed drugs pose more dangers for patients: unless newer drugs are clearly better, doctors and patients best stick with tried-and-true medications. |
Gordon, Dr., Guyatt |
|
Jan 1, 2003 |
999 |
| GENEDATA DEBUTS TWO MODULES FOR SCREENER SOFTWARE SYSTEM. |
|
Brief Article |
Jan 1, 2003 |
488 |
| Placebos sometimes work. |
|
Brief Article |
Dec 22, 2002 |
143 |
| Salk Institute becomes AIDS-knowledge hub: hopes hinge on bringing researchers' promising compounds into one center will lead to faster treatment. (Biotech). |
Webb, Marion |
|
Dec 9, 2002 |
631 |
| Myriad Genetics Inc. (Salt Lake City). |
|
Brief Article |
Dec 1, 2002 |
46 |
| He follows the sun: howard Asher continues to tout high-tech's value in the Biotech community. (Profile: Howard Asher). |
Webb, Marion |
|
Nov 25, 2002 |
1247 |
| Drug patents and developing countries: Problems remain. |
James, John S. |
|
Nov 22, 2002 |
578 |
| Researchers begin study on prescription & dietary supplement combination. (Industry News). |
|
Brief Article |
Sep 1, 2002 |
71 |
| ISPE guide seen helpful for post-approval scale-ups, but FDA wants validation specified. (Tech transfer). |
Ludwig, Elisa |
|
Sep 1, 2002 |
899 |
| Earlham College lab controls, Part 11 requirements called into question. (Human drugs). |
Witkowski, Wallace |
Brief Article |
Sep 1, 2002 |
235 |
| Agency slams AlloSource on moldy tissue. (Blood/Biologics). |
|
Brief Article |
Sep 1, 2002 |
165 |
| PAT, team audits, revamped guidance seen before new GMP rules for drugs, Woodcock says. (Process validation). |
Reid, Ken; Huegel, Kelly |
|
Aug 1, 2002 |
1528 |
| Pharmaceuticals for the 21st century: key points of the initiative. |
Huegel, Kelly |
|
Aug 1, 2002 |
368 |
| Antibody membrane lends a hand. (Molecule Sorting). |
Gorman, J. |
Brief Article |
Jun 22, 2002 |
361 |
| An effective new strategy promises quick results. (Window on Washington). |
Bartek, Raychel; Bartek, Ron |
|
Jun 22, 2002 |
646 |
| Adverse drug reactions seen after approval in 10% of drugs. (FDA Standards Questioned). |
Mahoney, Diana |
Brief Article |
Jun 1, 2002 |
417 |
| Myriad Genetics. (Around Utah in the News). |
|
Brief Article |
May 1, 2002 |
49 |
| Congressional act encouraging clinical trials of medications for children to expire. (Legislative Update). |
Chamalian, David |
Brief Article |
Jul 1, 2001 |
276 |
|
